Tarbox Family Office’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,000
Closed -$126K 1192
2021
Q3
$126K Hold
1,000
0.02% 157
2021
Q2
$135K Buy
+1,000
New +$131K 0.02% 158

Other funds holding XBI

Tarbox Family Office's XBI Position: Q4 2021 in Review

Tarbox Family Office sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 1,000 shares — an estimated $126K sold.

Tarbox Family Office first reported a position in XBI in Q2 2021 and held it in 2 quarters. The position peaked at $135K in Q2 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

  • Tarbox Family Office reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
  • Tarbox Family Office sold 1,000 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $126K.
  • Tarbox Family Office first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 2 quarters.
  • Tarbox Family Office's State Street SPDR S&P Biotech ETF position peaked at $135K in Q2 2021.
  • 702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.